Harte-Hanks (HHS) Tops Q3 EPS by 53c
Tweet
Share
E-mailGet Alerts HHS Hot Sheet
Price: $4.25 -0.47%
Financial Fact:
Total nonoperating expenses (income): 814K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
Total nonoperating expenses (income): 814K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Harte-Hanks (NASDAQ: HHS) reported Q3 EPS of $0.83, $0.53 better than the analyst estimate of $0.30. Revenue for the quarter came in at $53.9 million versus the consensus estimate of $49.4 million.
For earnings history and earnings-related data on Harte-Hanks (HHS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- Bernstein SocGen Group Reiterates Outperform Rating on Robinhood Markets (HOOD)
- Raymond James Downgrades Phreesia Inc. (PHR) to Market Perform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
